EUVIMEDEUVIMED entdecken
Crossref

Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma

Jie Liu, Yung-Ting Chang, Yan-Yu Kou, Pei-Pei Zhang, Qing-Li Dong, Ruo-Yu Guo, Li-Yun Liu, Hou-Wen Lin, Fan Yang

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02448-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Jie Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Research Center for Marine Drugs, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Oceanic Interdisciplinary Program of Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesAlkaloidsXenograft Model Antitumor AssaysApoptosisHumansAnimalsCell Line, TumorMicePoriferaMice, NudeCell ProliferationMice, Inbred BALB CAntineoplastic Agents

Stichwörter der Autor:innen

AaptamineDiffuse large B-cell lymphoma (DLBCL)Marine spongePI3K/AKT Signaling pathway

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAlkaloidsMTOR protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Research Center for Marine Drugs, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Marine Biological Injury and Dermatology, Naval Special Medical Center, Naval Medical University, Shanghai, 200052, China. z569977469@sina.com.
  • School of Health Science and Engineering, University of Shanghai for Science and Technology, 516 Jungong Road, Shanghai, 200093, China.
  • Key Laboratory of Marine Ecosystem Dynamics, Second Institute of Oceanography, Ministry of Natural Resources, 36 Baochubei Road, Hangzhou, 310012, China.
  • Department of Pharmacy, Research Center for Marine Drugs, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. linhouwen@renji.com.
  • Department of Pharmacy, Research Center for Marine Drugs, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. yang-fan@sjtu.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Oceanic Interdisciplinary Program of Shanghai Jiao Tong University
  • Eastern Young Scholars Program

Zitieren

APA

Liu, J., Chang, Y. T., Kou, Y. Y., Zhang, P. P., Dong, Q. L., Guo, R. Y., Liu, L. Y., Lin, H. W., & Yang, F. (2024). Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma. Medical Oncology. https://doi.org/10.1007/s12032-024-02448-9

Vancouver

Liu J, Chang YT, Kou YY, Zhang PP, Dong QL, Guo RY, et al. Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma. Medical Oncology. 2024. doi:10.1007/s12032-024-02448-9

BibTeX
@article{Liu2024,
  author = {Liu, Jie and Chang, Yung-Ting and Kou, Yan-Yu and Zhang, Pei-Pei and Dong, Qing-Li and Guo, Ruo-Yu and Liu, Li-Yun and Lin, Hou-Wen and Yang, Fan},
  title = {Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02448-9}
}
Kostenlos starten →